Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Col-3 Administered on a Continuous Daily Oral Schedule in Patients With Recurrent High-Grade Astrocytoma

NCT00004147 is registered in ClinicalTrials.gov with New Approaches to Brain Tumor Therapy Consortium as lead sponsor.

NCT NCT00004147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Col-3 Administered on a Continuous Daily Oral Schedule in Patients With Recurrent High-Grade Astrocytoma
Lead sponsor
New Approaches to Brain Tumor Therapy Consortium
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2000
Completion date
November 30, 2006
Enrollment
Not reported
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors